Exercise of Options & Total Voting Rights

Summary by AI BETAClose X

Intercede Group PLC has announced the exercise of 200,000 employee share options, resulting in the issuance of 200,000 new ordinary shares. These new shares are expected to be admitted to trading on AIM on January 22, 2026, and will rank pari passu with existing shares. Following this issuance, the company's total number of ordinary shares in issue will be 60,536,452, with 60,162,546 shares carrying voting rights, which shareholders can use for notification calculations under FCA rules.

Disclaimer*

Intercede Group PLC
15 January 2026
 

15 January 2026

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

Exercise of Options & Total Voting Rights

 

Intercede, the leading cybersecurity software company specialising in digital identities, announces that it has received notice of exercise (the "Exercise") in relation to employee share options over 200,000 share options over ordinary shares of 1p each in the Company ("Ordinary Shares") pursuant to the Company's Enterprise Management Incentive Plan.

 

To satisfy the Exercise, the Company is issuing 200,000 new Ordinary Shares. Accordingly, application has been made for 200,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 22 January 2026.

 

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company will have 60,536,452 Ordinary Shares in issue. The Company currently holds 373,906 Ordinary Shares in treasury, therefore the total number of Ordinary Shares with voting rights is 60,162,546. Accordingly, the figure of 60,162,546 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Marc Milmo/Fergus Sullivan/Trisyia Jamludin

Corporate Finance

Tim Redfern

Corporate Broking

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

 

For more information visit: www.intercede.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings